Calpains are cysteine proteases involved in the development of several human chronic illnesses such as neurodegenerative diseases, cardiovascular ailments, diabetes, and obesity which constitutes them into possible therapeutic targets. Here, using molecular dynamic simulations and docking, we studied the binding of known inhibitors to representative members of classical and nonclassical calpains. Our aim is to gain better understanding on the inhibition mechanism of calpains and to develop better and more specific inhibitors. Our atomistic models confirmed the importance of calcium ions for the structure of calpains and, as a consequence, their functionality. With these models and their subsequent use in molecular docking, essential structural requirements were identified for the binding of ligands to the calpain catalytic site that provide useful information for the design of new selective calpain inhibitors.
| INTRODUCTION
Calpains are nonlysosomal cysteine proteases that are activated by different concentrations of intracellular calcium, transducing it into a proteolytic cue and, thus, intervening in several signal transduction pathways [1] such as degradation of p53 [2] ; apoptosis in neurons and hepatocytes [3, 4] ; cell migration, cytoskeleton organization, autophagy, plasma membrane repair [5] ; and tumorigenesis and cellular migration. [6] To the date, fourteen calpain isoforms have been identified. Of these, calpains 1, 2, 5, and 10 are known to be involved in several pathological states including Huntington's disease, [7] Alzheimer's disease, [1, 8] stroke, [9] obesity, [10] metabolic syndrome, [11] and type-2 diabetes mellitus [12, 13] among others.
The wide variety of physiological functions in which calpains are involved and their ubiquitous expression in various tissues are the determinants on why they have a crucial role in diverse human pathologies:
The underlying cause of Huntington's disease is a mutation that results in the expansion of the polyglutamine region in the N-terminus of the protein huntingtin. Further evidence suggests that calpains (not caspases as it was previously thought [14] ) are involved in producing the proteolysis of huntingtin protein in a pathologic manner.
In Alzheimer's disease (AD), calpains 1 and 2 have been proposed as secretases responsible for the normal processing of the amyloid precursor protein (APP). [15] The data suggest that a subclinical decrease in calpain activity alters APP processing toward the production of amyloid protein (Aβ). The rise in Aβ concentration could then result in the activation of the NMDA receptor which, in turn, leads to hyperactivation of calpain and the negative consequences of a persistent calpain activity. In addition, the proteolytic activity of calpain I over tau, a protein found in the brain of patients with AD, is related to the necrotic cell death present in AD. [16] Therefore, in order to provide a therapeutic benefit, it is not sufficient to block calpain activity; further research is required in order to define the full role of calpains in the pathogenesis of Alzheimer's disease and the effects of the calpain substrates and inhibitors on neuronal failure. [17] It has been reported that the polymorphism that affects the expression of Calpain 10 is associated with an increase in obesity risk in children. [18] The mechanism by which calpains are associated with the development of obesity and metabolic syndrome is not elucidated, but it is possible that differences at calpain 10 locus or near it are responsible for obesity predisposition. [19] Furthermore, there is evidence suggesting that calpain 10 acts as a regulator of insulin [20] which reinforces the role of this calpain in the risk of diabetes and metabolic syndrome in Mexican-American, Northern European, and Korean populations. [21, 22] Other calpains, such as calpains 5 and 3, seem to be related to the development of obesity and metabolic syndrome. Gene variants of calpain 5 have been associated with obesity, hypertension, and dyslipidemia. [23] Lower calpain 3 gene expression in skeletal muscle is associated with elevated circulating glucose and insulin as well as abdominal fat accumulation. [24] According to the structural nature of the calcium-binding domain, calpains are classified in two main groups: classical calpains (heterodimeric proteins with "canonical" calmodulin-like calcium-binding domain, also known as PEF-hand) and nonclassical calpains (monomeric proteins with no recognizable PEF-hand). The classical and nonclassical calpains also differ in the structure of the catalytic subunit. The catalytic subunit of classical calpains is constituted by four domains: Domains I and II are the catalytic cores, domain III is the domain binding to calcium and phospholipids, and domain IV contains five EF-hands (as above mentioned); the fifth EF hand serves to bind to a dimer or to a small subunit. The catalytic subunit of the nonclassical calpains has also domains I and II, but not all have domains III and IV, and some contain other types of domains (Supporting information Figure S1 ). [25, 26] PEF (penta Helix-Loop-Helix) domains are crucial for heterooligomer formation for calpains 1 and 2. [27] This classification could be useful for studying the structure of calpains, which could lead to better design of calpains inhibitors. To prove this hypothesis, we selected the calpains 1 and 2 as example of classical calpains and the calpains 5 and 10 as examples of nonclassical ones. Currently, there are three structures of human calpains 1 [28, 29] and 2 [30] solved by X-ray diffraction and deposited in the PDB [31] ; experimental structures of calpains 5 and 10 are not available. The structure of calpain 2 is reported in its inactive native state [32, 33] with no calcium bound to the PEF-domain, which is a common substructure of all "classical" calpains that is involved in enzymatic activation by conformational changes due to hexa-co-ordination of calcium ions with acidic (aspartate or glutamate) and polar amino acids (asparagine and glutamine). [34] A homology model of Calpain 10 has been previously reported [35] to study the native structure [36] as well as the binding of a known calpain inhibitor SNJ-1715 to this protein and pentapeptide-like inhibitors. [37] For the design of new and highly selective calpain inhibitors, high-quality calpain structures in their active state are needed as tools to design new drug alternatives to the therapeutic treatment for a diversity of worldwide spread diseases.
| METHODS AND MATERIALS

| Homology modeling of calpains 5 and 10
Homology models of calpains 5 and 10 were constructed in the Robetta Server [38] using the BLAST sequences of canonical structures of calpains 5 and 10 obtained from the Universal Protein Resource. [39] The models were prepared without calcium ions; these were later added using R. norvegicus (PDB: 3BOW) [27] and H. sapiens (PDB: 1ZCM) [28] calpain 1 structure as templates using the Schrödinger-MaeStro©9.7 software 2015-4. Two calcium atoms were attached per protein, with further structure minimization with OPLS2006, which is available in the Protein Preparation Wizard [40] of the Maestro suite.
| Molecular dynamics
Once the structures were constructed, they were submitted to 200 ns of molecular dynamics simulations using aMber 14 (2014). Briefly, both structures with and without calcium ions were prepared with xLeap, then minimized for 200 ps with position restrains and periodic boundary conditions, followed with 200 ps without position restrains, 500 ps of temperature equilibration with restrains, and finally 500 ps of temperature equilibration without restrains. This was followed by a 200-ns production phase in an isobaric ensemble at 1 atm, 300 K with Langevin thermostat TIP4PEW water model, and Shake algorithm for hydrogens. All the simulations were performed
using the GPU-optimized code for aMber 14, [41, 42] and the analysis was performed in R (Language and Environment for Statistical Computing) using the packages bio3d [43] and ggplot2 [44] with GAM method [45] for smoothing graphs.
| Molecular docking of known calpain inhibitors
The most representative conformation of each molecular dynamic simulation was used to perform molecular docking of a series of known calpains 1 and 2 inhibitors using Glide [46] a in the Maestro suite. The structure of the calpain inhibitors was acquired in the ZINC database (ZINC12) [47] and prepared for docking in the Ligand Preparation Wizard, using a grid box of 20 Å centered on the catalytic triad and docked with standard precision (SP). The docking was performed in the centroid of the catalytic triad with standard precision (Glide-SP).
| RESULTS AND DISCUSSION
| Homology modeling of calpains 5 and 10
The catalytic sites of calpain 5 (342 residues) and calpain 10 (324 residues) were submitted to the Robetta server, and the best five models were obtained. Despite both structures belonging to the nonclassical calpains, the Robetta server found the structures of classical calpains 1 and 2 as suitable templates (PDB: 1ZCM, [28] 1KFU, [14] and 1KFX [30] ). Table 1 is the identity matrix of the sequences used.
Despite of calpain 10 having the lowest identity nonclassical calpains had several domains conserved when compared to the classical calpains that could explain why Robetta selected those structures for homology modeling (for the alignment, see Supporting information Figure S2 ).
The quality of the best model obtained from Robetta was assessed using web-based procheck b and Molprobity [48] [49] [50] servers as an external quality control different from the criteria used in Robetta server. Robetta server uses an algorithm divided into three phases: first performs a search for the most suitable sequence for template by sequence alignment and identity, later builds the model by comparative modeling to finally refine the model and loops by de novo structure prediction [38] ; this algorithm is constantly validated and is considered one of the leading approaches for homology modeling. [50] As expected, both servers found the models built in Robetta as appropriate, since both servers determined that most of the residues (>98%) were in allowed conformations as depicted in the Ramachandran plots of each model (see Supporting information Figure S3A ,B). Previous studies show that calpains have different conformations: open and closed (inactive and active, respectively), and the binding of calcium in the active state is highly dependent on these conformations. [33, 51] The homology models for calpains 5 and 10, although built based in two open (1KFU, 1KFX) and two closed (1ZCM, 2ARY) conformations, greatly resemble the closed conformation, as evidenced by the calculated root-mean-square deviation (RMSD) among the template and homology models in Table 2 and as depicted in Figure 1 . They do deviate significantly from the open conformation. The reason for this bias is not clear; however, we consider that our models can be used to represent the active calpain structures and not duplicates of similar conformational states.
As the models lack calcium, calcium ions were added by alignment with two structures containing those ions. Once the ions were placed, a heavy-atoms geometry optimization was performed near the catalytic site, which led to the correct hexa-co-ordination of the calcium ions with mainly polar residues or amide moieties in the protein backbone as shown in Figure 2 . The residues and water molecules that interact with the calcium ions are listed in Table 3 .
| Molecular dynamics of calpains
Once the structures were constructed, molecular dynamic simulations for each calpain with and without calcium ions were performed. As seen in the RMSD (root-meansquare deviation of atomic positions) of the Cα atomic coordinates (See Supporting information Figure S4A ), the simulations on the production stage were stable with and without calcium (See Supporting information Figure S4B ). The major changes are seen between both structures of calpains 5 and 10, which present more variation than calpains 1 and 2; calpains 5 and 10 could present more movement, as shown by an increase in RMSD form, the starting conformation of each simulation. This is due to calpains 5 and 10 being nonclassical calpains and contains several loops near the catalytic site that differentiates them from the classical calpains. [51] Since classical calpains were used as a template, a significant divergence from the starting conformation is expected.
Residue fluctuation could also be dependent on the type of calpain. This type of oscillation, expressed as the difference between root-mean-square fluctuation (RMSF) of the calpain with and without calcium ions, is shown in Figure 3 . It is worth pointing out that movements of the structures with calcium match the movements of the structures without calcium (See Supporting information Figure S5 ), and these movements could be related to the type of calpain, since the classical calpains move in a certain different pattern to the nonclassical calpains (Supporting information Figure S5A ).
In the case of the nonclassical calpains, the RMSF shows that the RMSD changed drastically during the simulation possibly due to the N-terminal residues (these regions are absent in classical calpain models). Moreover, the residues near the calcium-binding site in nonclassical calpains present more movement (RMSF < 0), specifically loop N1 (99-132) where nonclassical calpains present additions to the loop compared with the classical calpains in which these additions are absent.
For further analysis of the molecular dynamics simulations, the evaluation of the conformational space sampling (expressed as the anisotropic movement) and the simulation of Eigenvalues were calculated. Anisotropic analysis showed the residues responsible for major conformational changes near loops and calcium ions (See Supporting information Figure S6A ). It is worth mentioning that the structures used in this study consider only the catalytic unit of calpains, and thus, it is expected that the complete structure could present different anisotropic behavior. In the other hand, the calculated Eigenvalues show that the simulations explored the conformational space properly and that they are representative of the general movement of the structures studied in this research article (See Supporting information Figure S6B ).
As part of our interest on the design of new calpain inhibitors and due to the inhibition of the catalytic capacity of calpains (which constitutes the main mechanism of action in calpain inhibitors), it is important to assess the movement of the catalytic site. The area defined by the Water (2) Water (2) Glu157 Gln64
Water (1) Water (1) Calcium catalytic triad (Cys-His-Asn) was measured; in all cases, the structure without calcium presented more movement of those residues than their counterpart with calcium, except in calpain 10 (see below). In nonclassical calpains, the calcium-bound structure presented more movement, even a radical change of movement in calpain 5, as shown in Figure 4 .
To further explore the movement of the catalytic triad, RMSF and RMSD of those residues were calculated. As shown in Table 4 , calpains 1 and 10 showed more fluctuation of the catalytic site without calcium ions, while fluctuation in calpains 2 and 5 was higher in the structure with calcium ions. Moreover, the RMSD plots (See Supporting information Figure S7) show that the catalytic cysteine has major conformational changes during the simulation, where calpain 2 showed the greatest fluctuation along the simulation (as observed with or without calcium). Except for calpain 2, the rest of the models without calcium showed more changes in the catalytic cysteine than their corresponding structures with calcium; this is relevant due to the models without calcium being considered active conformation of the calpains [30, 52] and the paramount importance of this residue in the catalytic cycle as nucleophilic agent that initiates the proteolytic reaction. In the other hand, movements of histidine and asparagine are clearly different between classical and nonclassical calpain models, while in classical calpains, these residues possess little movement that does not change due to the presence of calcium ions. Conversely, nonclassical calpains possess great movement of asparagine to moderate movement of histidine when the ions are present (See Supporting information Figures  S8, S9 , and S10). These movements are important to the catalytic activity and for the design of new inhibitors due to the selectivity as a product of specific conformations of these residues. [53] Finally, a cluster analysis using Cα-RMSD correlation matrixes was performed to obtain the most representative conformation of each simulation (See Supporting information Figure S11 ). For the extraction of the representative structure of each simulation, a backbone RMSD cutoff of 1.5 Å was used for classical calpains and 2.0 Å for nonclassical ones due to the increased movement registered by nonclassical calpains, denoted by a higher RMSD in Supporting information Figure S12 . In general, the representative structures were found around 100 ns of simulation times, classical calpains showed a smaller number of clusters when compared to nonclassical calpains. The specific simulation timeframe of the representative structure, used for docking calculations, is shown in Figure 5 , where the conformation of the catalytic residues in the representative structure was greatly modified from the first frame (in gray) in all structures independently of the presence of calcium.
| Molecular docking of known calpain inhibitors
Doing a database search, we found 1,012 inhibitors of calpains 1 and 521 inhibitors of calpain 2 in the ZINC database (ZINC12) [47] ; most of them are active against calpains 1 and 2, with a few being selective; others lack reported activity to calpain 1 or 2. All of these compounds show a weak correlation between experimental affinities and docking score, as shown in Figure 6 ; this correlation was improved with the classification of the compounds in reactive/nonreactive by Maestro, and the nonreactive compounds show a better correlation between experimental and calculated affinity. It is worth mentioning that the most active compounds are considered as reactive ligands due to the presence of an α-ketocarbonyl, α-β-unsaturated carbonyl, ester, hemiacetal, or an aldehydic moiety in the structure. Those moieties would react in a Michael-type reaction with the catalytic cysteine causing an irreversible inhibition of the calpains, process that could not be predicted nor studied with the calculation used in this study.
Most of the docked conformations were positioned near the catalytic residues or at the large entrance to the catalytic site; there were compounds that were positioned in alternative sites that were discarded due to the rest of the protein would be in this position. Conversely, in the nonclassical calpains, an alternative site was below the entrance to the catalytic site, where diverse ligands could react with different cysteines from the catalytic site such as Cys150 in calpain 5 and Cys130 and 136 in calpain 10, being calpain 10 the most defined site and, therefore, constituting an important site for selectivity of new inhibitors. Nevertheless, the interaction of the inhibitors with the vicinity of the catalytic cysteine influences greatly the possibility of the reactive moiety to effectively react with the cysteine, and thus, a better docking score could be related to an improved interaction between the vicinal residues to the catalytic site and the inhibitors.
As previously reported, [54] the lack of specific calpain inhibitors and the difficult isolation of calpains hamper the identification of novel selective calpain inhibitors.
Computational techniques could help in the identification of these selective inhibitors. In order to assess the calculated affinity of known calpain inhibitors to nonclassical calpains, molecular docking of these inhibitors was performed in the calcium-bound structure of calpains 5 and 10. The docking of 1,066 known calpain inhibitors allowed us to create a general profile that is shown in Supporting information Figures S13 and S14. Except for calpain 10, the compounds show better affinity to structures with calcium ions, which is expected since these inhibitors are expected to bind to the active conformation. Calpains in their native state are inactive, and when the calcium ions bind to the proper domain, their proteolytic activity is triggered. [55] This differential behavior is highlighted if the ligands are classified as reactive/nonreactive compounds; in calpains 1 and 10, the affinity for reactive ligands is slightly greater to the noncalcium model compared to the affinity for reactive ligands in calpains 2 and 5 where they bind with higher affinity to the calcium model. As stated above, the differential behavior could provide valuable information for the design of highly selective calpain inhibitors with a distinct mechanism of action, such as suicide inhibitors (reactive ligands) or competitive inhibitors (nonreactive ligands). A statistical analysis of the docking scores by calpain showed that the compounds were better scored in the classical calpains than in the nonclassical (p < 0.05), which is somewhat expected since those compounds were designed for classical calpains. Conversely, due to the similarity of the experimental inhibition reported for the compounds that bind to both calpains 1 and 2, these compounds could not be considered as selective since the difference of pKi between those calpains is not greater than 2 logarithmical units. Thus, it is of great importance to identify the residues relevant to the interaction of calpains to compounds which show a significant difference in experimental inhibition, as well as common interactions of ligands to both classical and nonclassical calpains. A summary of the main interaction types and residues involved found by docking calculations is shown in Table 5 ; the interactions listed are those which were present in 60% or more of the cases, except for the hydrogen bonds, considered to be present in 25% of the cases, salt bridges and π-interactions to be present in any case. Despite the great number of good contact points and hydrophobic interactions, these interactions are present among several residues but are weak and unspecific. Nevertheless, all calpains, regardless of the presence of calcium, interact with the ligands by π-π interactions formed with a tryptophan near the catalytic asparagine; calpain 10 could form this type of interaction additionally with catalytic histidine providing an interesting [1] CYS 115 (30.6%) [1] GLU 261 (59.7%) [1] GLN 109 (38.4%) [1] GLU 261 (58.3%) [1] GLY 103 (33.9%) [1] GLU 251 (39.6%) [1] CYS 105 (31.4%) [1] SER 241 (34.5%) [1] ALA 263 (26.6%) [1] GLU 241 (31.0%) [1] TRP 286 (54.3%) [1] GLY 287 (33.2%) [1] GLN 75 (27.0%) [1] ARG 243 (75.6%) [1] GLU 233 (33.4%) [1] HIS 238 (48.2%) [1] ARG 267 (43.6%) [1] LEU 70 (42.7%) [1] HIS 238 (32.0%) [1] ARG 267 (64.4%) [1] Salt bridges GLU 261 (6.4%) [1] LYS 79 (13.8%) [1] --GLU 241 (5.0%) [1] ARG 243 (21.3%) [1] ARG 267 (7.2%) [1] ARG 267 (15.0%) [1] π-π interactions TRP 298 (17.8%) [2] TRP 298 (25.8%) [2] TRP 106 (8.2%) [1] HIS 262 (6.8%) [1] TRP 288 (20.8%) [1] TRP 106 (11.6%) [1] HIS 262 (5.8%) [1] TRP 288 (8.7%) [1] HIS 74 (8.4%) [1] HIS 151 (7.0%) [1] TRP 286 (19.3%) [1] TRP 286 (18.4%) [1] HIS 238 (20.1%) [1] TRP 74 (10.0%) [1] TRP 166 (9.9%) [1] HIS 238 (21.1%) [1] PHE 240 (5.8%) [1] TRP 265 (10.3%) [1] Good contacts GLN 109 (94.1%) [39] LEU 112 (75.3%) [12] GLY 113 (97.7%) [24] ASP 114 (78.4%) [8] CYS 115 (88.5%) [25] TRP 116 (63.6%) [15] MET 260 (72.5%) [12] GLU 261 (98.5%) [32] GLY 271 (69.9%) [10] TRP 298 (82.3%) [33] LYS 79 (78.9%) [21] GLN 109 (94.6%) [28] GLY 110 (73.7%) [7] ALA 111 (82.4%) [12] LEU 112 (83.8%) [17] GLY 113 (97.0%) [14] ASP 114 (98.1%) [18] CYS 115 (88.2%) [16] TRP 116 (67.0%) [15] MET 260 (95.8%) [19] GLU 261 (98.3%) [29] GLY 271 (75.6%) [10] TRP 298 (84.9%) [36] GLU 300 (64.2%) [11] ALA 101 (86.2%) [19] LEU 102 (84.5%) [19] GLY 103 (79.7%) [13] CYS 105 (90.6%) [12] TRP 106 (60.9%) [24] GLU 251 (94.3%) [28] VAL 259 (73.1%) [9] LYS 260 (71.4%) [5] GLY 261 (94.5%) [17] HIS 262 (97.1%) [18] TRP 288 (93.1%) [45] TRP 288 (74.8%) [7] GLN 99 (60.7%) [12] ASP 104 (88.4%) [15] CYS 105 (97.2%) [28] TRP 106 (83.6%) [32] LEU 238 (61.5%) [12] GLY 239 (78.8%) [23] SER 241 (88.7%) [18] GLY 261 (97.7%) [20] HIS 262 (94.7%) [24] ALA 263 (96.1%) [25] ARG 337 (76.2%) [15] GLU 339 (83.5%) [26] HIS 74 (77.5%) [25] GLN 75 (93.3%) [8] GLY 76 (95.0%) [13] GLN 77 (98.1%) [42] VAL 78 (89.5%) [20] GLY 79 (84.7%) [15] HIS 151 (86.4%) [16] ASP 178 (63.2%) [10] GLU 241 (94.7%) [27] TRP 286 (99.5%) [42] GLY 287 (87.6%) [28] GLU 288 (61.0%) [16] GLN 75 (99.2%) [30] GLY 76 (87.9%) [9] GLN 77 (95.8%) [26] VAL 78 (61.3%) [5] GLY 79 (82.3%) [20] GLU 241 (94.5%) [29] ARG 243 (99.9%) [40] VAL 249 (98.4%) [20] HIS 252 (93.9%) [15] TYR 254 (72.0%) [13] ASN 284 (89.7%) [18] TRP 286 (99.9%) [ 
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GLU 288 (95.4%) [7] ARG 289 (95.3%) [27] GLN 67 (67.4%) [6] LEU 70 (90.6%) [27] CYS 73 (92.7%) [22] GLU 233 (86.1%) [37] LEU 234 (72.6%) [10] GLY 235 (78.9%) [14] GLU 236 (79.4%) [20] PHE 237 (74.3%) [16] HIS 238 (99.7%) [55] ALA 239 (68.8%) [17] PRO 264 (60.1%) [14] TRP 265 (93.1%) [27] ARG 267 (84.9%) a LEU 69 (86.0%) [22] LEU 70 (99.1%) [40] GLY 71 (83.2%) [17] TRP 166 (60.8%) [13] GLU 233 (95.9%) [28] GLY 235 (86.3%) [16] GLU 236 (64.7%) [18] HIS 238 (99.0%) [25] TRP 265 (78.3%) [20] ARG 267 (92.6%) [23] ARG 268 (92.1%) [19] (Continues) selectivity point for this kind of calpains. Furthermore, salt bridges are strong interactions that are seldom formed with the calpain ligands; nevertheless, nonclassical calpains form these interactions with basic amino acids, whereas classical calpains do not. Finally, classical calpains form hydrogen bonds with acidic and polar amino acids, including catalytic cysteine; in nonclassical calpains, those interactions are formed with basic amino acids, particularly catalytic histidine in calpain 10. All the previous observations bring forth valuable insight that is useful for the design of new selective calpain inhibitors. Finally, SNJ-1715 is considered a lead compound for the design of selective calpain inhibitors; as such, there are previous articles that study the crystallographic and theoretical binding of this compound with classical and nonclassical calpains, [7, 35, 51, 56] which can be compared with the data generated as a validation of the study reported in this work.
As shown in Figure 7 , the thio-urea moiety forms a hydrogen bond with acidic amino acids in all calpains, in accordance to previous studies. This moiety serves as an anchor point that stabilizes a proper conformation of the ligand to make it suitable to the nucleophilic attack of the catalytic cysteine; aromatic residues can aid to anchor the ligand.
| CONCLUSIONS
All calpains share a preserved catalytic triad, which is also common to all cysteine proteases. However, due to their intrinsic structural differences, classical and nonclassical calpains have different dynamics that could be exploited to design selective calpain inhibitors. Designing selective calpain inhibitors is important as a search strategy for new possible treatments for several chronic diseases such as diabetes, cardiovascular diseases, obesity, and neurodegenerative diseases among others. Based on our models, their dynamics, and the available experimental data, we were able to tease out relevant information of the structural requirements for the optimization of calpain inhibitors. Indeed, the calpain inhibitors showed better affinity to classical calpains than nonclassical calpains, interesting the docking studies on nonclassical calpains allowed us not only to identify the residues that would be important for the binding of those compounds, but also to identify possible alternative binding sites to achieve greater selectivity in new compounds. Nevertheless, it is important to mention that, since known inhibitors are covalent in their mechanism of action, more information could be obtained using calculations that consider quantum effects such as QM/MM and ab initio molecular dynamics. These are, however, not currently feasible for use on a 
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(69.4%) [2] HIS 238 (65.8%) [2] TRP 265 (60.3%) [2] Hydrophobic -MET 260 (76.3%) [3] TRP 288 (74.8%) [7] ALA 263 (63.4%) [2] GLU 339 (59.9%) [2] -VAL 249 (78.9%) [4] TRP 286 (97.5%) [8] ARG 289 (65.3%) [1] -LEU 70 (66.4%) [2] Notes. The numbers in parentheses show the percentage of ligands that possess this interaction, and the numbers in brackets indicate the mean interactions found per ligand. Catalytic residues are shown in bold.
T A B L E 5 (Continued) great number of ligands. The results from this work are currently being completed with both calculations and experiments searching for new nonclassical calpain selective inhibitors.
